ZISES SELIG 4
4 · Esquire Financial Holdings, Inc. · Filed Mar 20, 2026
Research Summary
AI-generated summary of this filing
Esquire Financial (ESQ) Director Zises Selig Sells Shares
What Happened
Zises Selig, a director of Esquire Financial Holdings, sold a total of 30,000 shares in open-market transactions on March 18–19, 2026, generating proceeds of approximately $3,189,045. Individual sale prices ranged from $105.00 to $107.26 per share across multiple tranches (see details below). These filings report dispositions (sales), not purchases.
Key Details
- Transaction dates: March 18, 2026 and March 19, 2026.
- Shares sold: 30,000 total (25,000 on 3/18; 5,000 on 3/19).
- Price range: $105.00 – $107.26 per share.
- Total proceeds: ~$3,189,045.
- Transaction code: S (sale / disposition).
- Shares owned after the transactions: not specified in the provided excerpt.
- Footnotes in the filing (F1–F6) note holdings include restricted stock with various vesting schedules (vesting in annual installments starting December 2024, 2025, 2026, 2027 and one grant vesting 100% on Dec 10, 2026).
- Filing timeliness: Report filed March 20, 2026 (within the typical two-business-day Form 4 window for the reported dates).
Context
This Form 4 documents insider sales (dispositions). Sales are routine corporate-insider transactions for many reasons; the filing itself does not specify motivation. The footnotes indicate some reported holdings include restricted shares subject to future vesting schedules, which affects how many shares are immediately transferable vs. subject to vesting.
Insider Transaction Report
- Sale
Common Stock
2026-03-18$107.00/sh−8,500$909,500→ 12,501 total(indirect: By profit sharing plan) - Sale
Common Stock
2026-03-18$105.53/sh−2,000$211,070→ 10,501 total(indirect: By profit sharing plan) - Sale
Common Stock
2026-03-18$106.04/sh−2,000$212,086→ 8,501 total(indirect: By profit sharing plan) - Sale
Common Stock
2026-03-19$105.25/sh−2,000$210,500→ 6,501 total(indirect: By profit sharing plan) - Sale
Common Stock
2026-03-18$105.11/sh−1,500$157,672→ 77,533 total(indirect: By Trust) - Sale
Common Stock
2026-03-18$105.16/sh−2,000$210,327→ 75,533 total(indirect: By Trust) - Sale
Common Stock
2026-03-18$106.08/sh−1,500$159,120→ 74,033 total(indirect: By Trust) - Sale
Common Stock
2026-03-18$107.01/sh−1,500$160,515→ 72,533 total(indirect: By Trust) - Sale
Common Stock
2026-03-18$107.13/sh−2,000$214,250→ 70,533 total(indirect: By Trust) - Sale
Common Stock
2026-03-18$107.25/sh−3,000$321,750→ 67,533 total(indirect: By Trust) - Sale
Common Stock
2026-03-18$107.26/sh−1,000$107,255→ 66,533 total(indirect: By Trust) - Sale
Common Stock
2026-03-19$105.00/sh−3,000$315,000→ 63,533 total(indirect: By Trust)
- 15,716
Common Stock
[F1][F2][F3][F4][F5][F6] - 25,500(indirect: By Trust)
Common Stock
- 12,600(indirect: By L.P.)
Common Stock
Footnotes (6)
- [F1]Includes shares of restricted stock which vest in three equal annual installments commencing on December 16, 2024.
- [F2]Includes shares of restricted stock which vest in three equal annual installments commencing on December 9, 2025.
- [F3]Includes shares of restricted stock which vest 100% on December 10, 2026.
- [F4]Includes shares of restricted stock which vest in three equal annual installments commencing on December 19, 2026.
- [F5]Includes shares of restricted stock which vest in three equal annual installments commencing on December 3, 2027.
- [F6]Includes shares of restricted stock which vest in three equal annual installments commencing on December 15, 2027.